Clinical Trial Update: TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC) [Phase 3]

View source ↗

Summary

Phase 3 trial update for TP05 in mild to moderate active ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TP05

Snippet

Sponsor: Tillotts Pharma AG | Conditions: Acute Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2018-08-08